Mr Iiro Aalto
Etteplan provides engineering services and technical product information solutions to the world’s leading companies in the manufacturing industry. Our services are geared to improve the competitiveness of our customers’ products and engineering processes throughout the product life cycle.
Etteplan has a successful in helping customer develop state-of-the-art medical devices. Our services cover the entire development process including regulatory issues and strategies, CE-marking and energy storage related challenges. Etteplan also provides advanced technical product information services such as technical illustrations, user and spare parts manuals.
Etteplan
Regional directorDr Claus Andersson
Sunstone Life Science Ventures’ invests in early-stage Life Science companies in the therapeutic, medical technology and diagnostics fields. Our geographical scope is Europe with particular emphasis on the Nordic countries, Germany and Switzerland.
Our point of entry differs depending on the type of Life Science opportunity. In the therapeutic field, we invest when drug candidates are in the pre-clinical or clinical phase I. In the areas of medical technology and diagnostics, we tend to invest in companies just before the pivotal clinical trials required to support the intended use and marketing claims.
Sunstone Life Science Ventures investment strategy has a strong industry focus vis-à-vis potential buyers of our portfolio companies. Since we believe that most exits in the Life Science sector will continue to take place in the M&A space, we prefer business models suitable for this exit route. To appear on potential acquirers’ radar screens, we invest in opportunities that have the potential of becoming either a threat or a complement to existing products on the market. We look out for opportunities which target unmet medical needs in commercially attractive markets, and we seek products which, once approved, are likely to receive attractive reimbursement and pricing structures. We have a preference for companies targeting niche markets. In the therapeutic area, opportunities aimed at specialty pharma and orphan drug indications are especially interesting, whereas we consider opportunities aimed at widespread diseases already addressed by established medical treatment regimes less interesting.
We believe that the single most important factor when developing a successful company is the quality of the management team. This is not the same as saying that we only invest in savvy entrepreneurs with a strong track record. But less experienced management teams should be open to change if needed to accelerate the company.
Mr Jukkapekka Asikainen
Sensire Oy is a Finnish technology company specialized in wireless measuring and sensoring, logistics tracking and analytics with secure and scalable Cloud-service.
Sensire TempNet® Pharma-product is usable in medical industry with environmental monitoring and logistics tracking with wireless sensors used in cargo boxes, reception/delivery terminals and vehicles, in hospitals or pharmaceutical factories.
Solution ensure medicine safety from production or warehouse to distribution in hospital or other eq. medical facilities. Additional sensors can measure environmental variables, like temperature & harmful particles. One feature is to monitor bio samples taken from patients and securing item transportation and conditions from doctor’s reception to laboratory room.
Sensire's Pharma-solution offers technological excellence and own IPR, proven concept of service, security and archive, expandability with connectivity and global user access expansion possibility.